118 related articles for article (PubMed ID: 8495635)
21. Efficacy and safety of the 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor fluvastatin in hyperlipidemic patients treated with probucol.
Sasaki S; Nakagawa M; Nakata T; Endo N; Miyao K; Kitamura K; Fukuyama M; Kitani T; Yamada C
Cardiology; 1997; 88(2):160-5. PubMed ID: 9096917
[TBL] [Abstract][Full Text] [Related]
22. Comparative efficacy and safety of pravastatin and cholestyramine alone and combined in patients with hypercholesterolemia. Pravastatin Multicenter Study Group II.
Arch Intern Med; 1993 Jun; 153(11):1321-9. PubMed ID: 8507122
[TBL] [Abstract][Full Text] [Related]
23. Efficacy and safety of high-dose pravastatin in hypercholesterolemic patients with well-compensated chronic liver disease: Results of a prospective, randomized, double-blind, placebo-controlled, multicenter trial.
Lewis JH; Mortensen ME; Zweig S; Fusco MJ; Medoff JR; Belder R;
Hepatology; 2007 Nov; 46(5):1453-63. PubMed ID: 17668878
[TBL] [Abstract][Full Text] [Related]
24. Effects of probucol and pravastatin on common carotid atherosclerosis in patients with asymptomatic hypercholesterolemia. Fukuoka Atherosclerosis Trial (FAST).
Sawayama Y; Shimizu C; Maeda N; Tatsukawa M; Kinukawa N; Koyanagi S; Kashiwagi S; Hayashi J
J Am Coll Cardiol; 2002 Feb; 39(4):610-6. PubMed ID: 11849859
[TBL] [Abstract][Full Text] [Related]
25. Mode of hypocholesterolemic action of probucol in animals and man.
Beynen AC
Artery; 1987; 14(2):113-26. PubMed ID: 3551883
[TBL] [Abstract][Full Text] [Related]
26. Tolerability and effects on lipids of ezetimibe coadministered with pravastatin or simvastatin for twelve months: results from two open-label extension studies in hypercholesterolemic patients.
Strony J; Hoffman R; Hanson M; Veltri E
Clin Ther; 2008 Dec; 30(12):2280-97. PubMed ID: 19167588
[TBL] [Abstract][Full Text] [Related]
27. [Changes in lipid status during pravastatin treatment].
Craveri A; Colombo L; Citella C; Pedrazzini L; Altomare S; Giavardi L; Picollo S; Vignati A; Lanfredini M
Minerva Med; 1992 Nov; 83(11):695-703. PubMed ID: 1461540
[TBL] [Abstract][Full Text] [Related]
28. Effect of pravastatin treatment on glucose, insulin, and lipoprotein metabolism in patients with hypercholesterolemia.
Sheu WH; Shieh SM; Shen DD; Fuh MM; Jeng CY; Chen YD; Reaven GM
Am Heart J; 1994 Feb; 127(2):331-6. PubMed ID: 8296701
[TBL] [Abstract][Full Text] [Related]
29. Statins improve visual field alterations related to hypercholesterolemia.
Alcalá A; Jansen S; Téllez T; Gómez-Huelgas R; Pérez O; Egido J; Farkouh ME
Atherosclerosis; 2010 Apr; 209(2):510-4. PubMed ID: 19892351
[TBL] [Abstract][Full Text] [Related]
30. Effects of combined probucol-colestipol treatment for familial hypercholesterolemia and coronary artery disease.
Kuo PT; Wilson AC; Kostis JB; Moreyra AE
Am J Cardiol; 1986 Jun; 57(16):43H-48H. PubMed ID: 3524177
[TBL] [Abstract][Full Text] [Related]
31. New combined therapy of niceritrol and probucol on heterozygous familial hypercholesterolemia.
Yamamoto K; Fukushima N; Ozaki I; Setoguchi Y; Yanagita T; Sakai T
Artery; 1991; 18(3):133-49. PubMed ID: 2069518
[TBL] [Abstract][Full Text] [Related]
32. Comparative efficacy of once-daily versus twice-daily pravastatin in primary hypercholesterolemia.
Pan HY; DeVault AR; Brescia D; Willard DA
Clin Ther; 1991; 13(3):368-72. PubMed ID: 1954638
[TBL] [Abstract][Full Text] [Related]
33. Improvement in endothelial dysfunction with LDL cholesterol level < 80 mg/dl in type 2 diabetic patients.
Sheu WH; Chen YT; Lee WJ
Diabetes Care; 2001 Aug; 24(8):1499-501. PubMed ID: 11473096
[No Abstract] [Full Text] [Related]
34. Clinical and therapeutic use of probucol.
Berg A; Baumstark MW; Frey I; Halle M; Keul J
Eur J Clin Pharmacol; 1991; 40 Suppl 1():S81-4. PubMed ID: 2044650
[TBL] [Abstract][Full Text] [Related]
35. Effectiveness of probucol in reducing plasma low-density lipoprotein cholesterol oxidation in hypercholesterolemia.
Masana L; Bargalló MT; Plana N; LaVille A; Casals I; Solà R
Am J Cardiol; 1991 Oct; 68(9):863-7. PubMed ID: 1927944
[TBL] [Abstract][Full Text] [Related]
36. Efficacy and safety of cerivastatin and pravastatin in the treatment of primary hypercholesterolemia.
Saunders E; Ferdinand K; Yellen LG; Tonkon MJ; Krug-Gourley S; Poland M
J Natl Med Assoc; 2000 Jul; 92(7):319-26. PubMed ID: 10946527
[TBL] [Abstract][Full Text] [Related]
37. Effect of pravastatin in the treatment of hypercholesterolemia after renal transplantation under cyclosporine and prednisone.
Castelao AM; Grinyó JM; Castiñeiras MJ; Fiol C; Gilvernet S; Seron D; Torras J; Cruzado JM; Alsina J
Transplant Proc; 1995 Aug; 27(4):2217-20. PubMed ID: 7652779
[No Abstract] [Full Text] [Related]
38. Pravastatin in diabetes-associated hypercholesterolemia.
Rustemeijer C; Schouten JA; Janssens EN; Spooren PF; van Doormaal JJ
Acta Diabetol; 1997 Dec; 34(4):294-300. PubMed ID: 9451475
[TBL] [Abstract][Full Text] [Related]
39. Pravastatin and risk factor modification in patients with moderate primary hypercholesterolaemia.
Morris R; Robinson G; Tilyard M; Gurr E
N Z Med J; 1996 Aug; 109(1028):319-22. PubMed ID: 8816723
[TBL] [Abstract][Full Text] [Related]
40. Probucol further lowers the serum cholesterol of colestipol-treated patients with hypercholesterolemia.
Schonfeld G; Witztum J; Basich P
Artery; 1982; 10(2):99-104. PubMed ID: 7092583
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
